Multiple sclerosis: risk factors, prodromes, and potential causal pathways (Q37770795)

22 August 2017

1 reference

title

Multiple sclerosis: risk factors, prodromes, and potential causal pathways (English)

1 reference

22 August 2017

0 references

4

Gavin Giovannoni

1 reference

22 August 2017

author name string

Sreeram V Ramagopalan

series ordinal

1

1 reference

22 August 2017

Ruth Dobson

series ordinal

2

1 reference

22 August 2017

Ute C Meier

series ordinal

3

1 reference

22 August 2017

publication date

1 July 2010

1 reference

22 August 2017

1 reference

22 August 2017

volume

9

1 reference

22 August 2017

issue

7

1 reference

22 August 2017

page(s)

727-739

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970094-6

22 August 2017

1 reference

7 January 2021

Multiple sclerosis: the environment and causation.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970094-6

7 January 2021

The schizophrenia prodrome

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970094-6

7 January 2021

Clinically isolated syndromes suggestive of multiple sclerosis, part I: natural history, pathogenesis, diagnosis, and prognosis

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970094-6

7 January 2021

Incidental MRI anomalies suggestive of multiple sclerosis: the radiologically isolated syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970094-6

7 January 2021

The endophenotype concept in psychiatric genetics

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970094-6

7 January 2021

Genetics of multiple sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970094-6

7 January 2021

Age-adjusted recurrence risks for relatives of patients with multiple sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970094-6

7 January 2021

Multiple sclerosis: updated risks for relatives

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970094-6

7 January 2021

Twin concordance and sibling recurrence rates in multiple sclerosis.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970094-6

7 January 2021

Parent-of-origin effect in multiple sclerosis: observations in half-siblings

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970094-6

7 January 2021

Histocompatibility determinants in multiple sclerosis, with special reference to clinical course

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970094-6

7 January 2021

HLA-DR2 dose effect on susceptibility to multiple sclerosis and influence on disease course

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970094-6

7 January 2021

Dissection of the HLA association with multiple sclerosis in the founder isolated population of Sardinia

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970094-6

7 January 2021

Complex interactions among MHC haplotypes in multiple sclerosis: susceptibility and resistance

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970094-6

7 January 2021

Heterogeneity at the HLA-DRB1 locus and risk for multiple sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970094-6

7 January 2021

The inheritance of resistance alleles in multiple sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970094-6

7 January 2021

HLA-DRB1 and multiple sclerosis in Malta

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970094-6

7 January 2021

Epistasis among HLA-DRB1, HLA-DQA1, and HLA-DQB1 loci determines multiple sclerosis susceptibility

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970094-6

7 January 2021

Meta-analysis of genome scans and replication identify CD6, IRF8 and TNFRSF1A as new multiple sclerosis susceptibility loci

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970094-6

7 January 2021

Risk alleles for multiple sclerosis identified by a genomewide study

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970094-6

7 January 2021

Epidemiology of multiple sclerosis in U.S. veterans: 1. Race, sex, and geographic distribution

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970094-6

7 January 2021

Parent-of-origin effects in MS: observations from avuncular pairs.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970094-6

7 January 2021

Maternal Transmission of Multiple Sclerosis in a Dutch Population

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970094-6

7 January 2021

Parent-of-origin effect in multiple sclerosis: observations from interracial matings

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970094-6

7 January 2021

Epigenetics: molecular mechanisms and implications for disease.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970094-6

7 January 2021

Epigenetics in multiple sclerosis susceptibility: difference in transgenerational risk localizes to the major histocompatibility complex

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970094-6

7 January 2021

Sex ratio of multiple sclerosis in Canada: a longitudinal study.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970094-6

7 January 2021

Multiple sclerosis in US veterans of the Vietnam era and later military service: race, sex, and geography

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970094-6

7 January 2021

Increasing prevalence and incidence of multiple sclerosis in South East Wales

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970094-6

7 January 2021

Temporal trends in the incidence of multiple sclerosis: a systematic review

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970094-6

7 January 2021

Sex differences in autoimmune disease

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970094-6

7 January 2021

Environmental risk factors for multiple sclerosis. Part I: The role of infection

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970094-6

7 January 2021

Infectious mononucleosis and risk for multiple sclerosis: a meta-analysis

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970094-6

7 January 2021

An altered immune response to Epstein-Barr virus in multiple sclerosis: a prospective study

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970094-6

7 January 2021

Temporal relationship between elevation of epstein-barr virus antibody titers and initial onset of neurological symptoms in multiple sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970094-6

7 January 2021

Multiple Sclerosis After Infectious Mononucleosis

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970094-6

7 January 2021

Association of infectious mononucleosis with multiple sclerosis. A population-based study.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970094-6

7 January 2021

Clinical features and viral serologies in children with multiple sclerosis: a multinational observational study

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970094-6

7 January 2021

Pediatric multiple sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970094-6

7 January 2021

High seroprevalence of Epstein-Barr virus in children with multiple sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970094-6

7 January 2021

Smoking is a risk factor for multiple sclerosis: a metanalysis

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970094-6

7 January 2021

Cigarette smoking and incidence of multiple sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970094-6

7 January 2021

Tobacco smoking, but not Swedish snuff use, increases the risk of multiple sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970094-6

7 January 2021

Geographic distribution of multiple sclerosis: An update with special reference to Europe and the Mediterranean region

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970094-6

7 January 2021

The epidemiology of multiple sclerosis in three Australian cities: Perth, Newcastle and Hobart

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970094-6

7 January 2021

Vitamin D: a candidate for the environmental effect in multiple sclerosis - observations from Norway

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970094-6

7 January 2021

Multiple sclerosis characteristics in African American patients in the New York State Multiple Sclerosis Consortium

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970094-6

7 January 2021

Some comments on the relationship of the distribution of multiple sclerosis to latitude, solar radiation, and other variables

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970094-6

7 January 2021

Past exposure to sun, skin phenotype, and risk of multiple sclerosis: case-control study

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970094-6

7 January 2021

Vitamin D intake and incidence of multiple sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970094-6

7 January 2021

Wintertime vitamin D insufficiency is common in young Canadian women, and their vitamin D intake does not prevent it

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970094-6

7 January 2021

Potentially modifiable determinants of vitamin D status in an older population in the Netherlands: the Hoorn Study

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970094-6

7 January 2021

Serum 25-hydroxyvitamin D levels and risk of multiple sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970094-6

7 January 2021

Vitamin D and multiple sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970094-6

7 January 2021

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970094-6

1 reference

7 January 2021

Timing of birth and risk of multiple sclerosis: population based study

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970094-6

7 January 2021

Seasonal fluctuation of multiple sclerosis births in Sardinia

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970094-6

7 January 2021

Timing of birth and risk of multiple sclerosis in the Scottish population

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970094-6

7 January 2021

Multiple sclerosis in Israel. Prevalence among immigrants and native inhabitants

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970094-6

7 January 2021

Risk of Multiple Sclerosis Related to Age at Immigration to Israel

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970094-6

7 January 2021

Annual incidence, prevalence, and mortality of multiple sclerosis in white South-African-born and in white immigrants to South Africa

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970094-6

7 January 2021

Multiple sclerosis among Orientals and Caucasians in Hawaii

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970094-6

7 January 2021

On the Risk of Multiple Sclerosis According to Age at Immigration to South Africa

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970094-6

7 January 2021

Multiple sclerosis among immigrants in Greater London

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970094-6

7 January 2021

Epidemiology of multiple sclerosis in US veterans: III. Migration and the risk of MS.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970094-6

7 January 2021

Multiple sclerosis among the United Kingdom-born children of immigrants from the West Indies

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970094-6

7 January 2021

Multiple sclerosis among United Kingdom-born children of immigrants from the Indian subcontinent, Africa and the West Indies

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970094-6

7 January 2021

Age at immigration to England of Asian and Caribbean immigrants and the risk of developing multiple sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970094-6

7 January 2021

Multiple sclerosis in North African migrants to France.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970094-6

7 January 2021

The age-range of risk of developing multiple sclerosis: evidence from a migrant population in Australia

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970094-6

7 January 2021

The frequency of multiple sclerosis in jewish and arab populations in greater jerusalem

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970094-6

7 January 2021

Role of return migration in the emergence of multiple sclerosis in the French West Indies

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970094-6

7 January 2021

Marked differences in prevalence of multiple sclerosis between ethnic groups in Oslo, Norway

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970094-6

7 January 2021

Migrant studies in multiple sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970094-6

7 January 2021

Evidence of early childhood as the susceptibility period in multiple sclerosis: space-time cluster analysis in a Sardinian population

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970094-6

7 January 2021

Age of puberty and the risk of multiple sclerosis: a population based study.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970094-6

7 January 2021

Body size and risk of MS in two cohorts of US women

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970094-6

7 January 2021

Mortality from multiple sclerosis and exposure to residential and occupational solar radiation: a case-control study based on death certificates

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970094-6

7 January 2021

Cognitive function in recent-onset demyelinating diseases

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970094-6

7 January 2021

Mental change as an early feature of multiple sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970094-6

7 January 2021

A clinical patho-anatomical study of clinically silent multiple sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970094-6

7 January 2021

Unsuspected multiple sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970094-6

7 January 2021

Unexpected multiple sclerosis: follow-up of 30 patients with magnetic resonance imaging and clinical conversion profile

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970094-6

7 January 2021

Comparison of MRI criteria at first presentation to predict conversion to clinically definite multiple sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970094-6

7 January 2021

Disability and T2 MRI lesions: a 20-year follow-up of patients with relapse onset of multiple sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970094-6

7 January 2021

Early development of multiple sclerosis is associated with progressive grey matter atrophy in patients presenting with clinically isolated syndromes

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970094-6

7 January 2021

Relationships between gray matter metabolic abnormalities and white matter inflammation in patients at the very early stage of MS : a MRSI study.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970094-6

7 January 2021

Magnetization transfer histograms in clinically isolated syndromes suggestive of multiple sclerosis.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970094-6

7 January 2021

A 3-year diffusion tensor MRI study of grey matter damage progression during the earliest clinical stage of MS

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970094-6

7 January 2021

Multiple sclerosis immunology: The healthy immune system vs the MS immune system.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970094-6

7 January 2021

Treatment of multiple sclerosis with the monoclonal anti-CD4 antibody cM-T412: results of a randomized, double-blind, placebo-controlled, MR-monitored phase II trial

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970094-6

7 January 2021

Repeated subcutaneous injections of IL12/23 p40 neutralising antibody, ustekinumab, in patients with relapsing-remitting multiple sclerosis: a phase II, double-blind, placebo-controlled, randomised, dose-ranging study

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970094-6

7 January 2021

Loss of functional suppression by CD4+CD25+ regulatory T cells in patients with multiple sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970094-6

7 January 2021

Reduced suppressive effect of CD4+CD25high regulatory T cells on the T cell immune response against myelin oligodendrocyte glycoprotein in patients with multiple sclerosis.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970094-6

7 January 2021

Interleukin-17 production in central nervous system-infiltrating T cells and glial cells is associated with active disease in multiple sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970094-6

7 January 2021

Multiple sclerosis: Relation of in vitro IgG secretion to T suppressor cell number and function

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970094-6

7 January 2021

Oligoclonal expansion of memory CD8+ T cells in cerebrospinal fluid from multiple sclerosis patients

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970094-6

7 January 2021

CSF enrichment of highly differentiated CD8+ T cells in early multiple sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970094-6

7 January 2021

Strong EBV-specific CD8+ T-cell response in patients with early multiple sclerosis.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970094-6

7 January 2021

CSF analysis in suspected MS: do bands aid?

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970094-6

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970094-6

7 January 2021

Predicting the Outcome of Optic Neuritis

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970094-6

7 January 2021

Optic neuritis: prognosis for multiple sclerosis from MRI, CSF, and HLA findings

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970094-6

7 January 2021

Do oligoclonal bands add information to MRI in first attacks of multiple sclerosis?

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970094-6

7 January 2021

Natural Killer Cell Activity in Patients with Multiple Sclerosis: Interferon and Plasmapheresis

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970094-6

7 January 2021

Natural killer cell number and activity in multiple sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970094-6

7 January 2021

Enumeration of T, B and natural killer peripheral blood cells of patients with multiple sclerosis and controls

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970094-6

7 January 2021

Circulating natural killer cells but not cytotoxic T lymphocytes are reduced in patients with active relapsing multiple sclerosis and little clinical disability as compared to controls

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970094-6

7 January 2021

A role for natural killer cells in the immunopathogenesis of multiple sclerosis.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970094-6

7 January 2021

Natural killer type 2 bias in remission of multiple sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970094-6

7 January 2021

Clinical relapses of multiple sclerosis are associated with 'novel' valleys in natural killer cell functional activity

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970094-6

7 January 2021

The regulatory role of natural killer cells in multiple sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970094-6

7 January 2021

Regulatory CD56(bright) natural killer cells mediate immunomodulatory effects of IL-2Ralpha-targeted therapy (daclizumab) in multiple sclerosis.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970094-6

7 January 2021

Longitudinal analysis of immune cell phenotypes in early stage multiple sclerosis: distinctive patterns characterize MRI-active patients.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970094-6

7 January 2021

Expansion of CD56Bright natural killer cells in the peripheral blood of multiple sclerosis patients treated with interferon-beta

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970094-6

7 January 2021

Cytometric profiling in multiple sclerosis uncovers patient population structure and a reduction of CD8low cells

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970094-6

7 January 2021

A randomized, placebo-controlled trial of natalizumab for relapsing multiple sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970094-6

7 January 2021

Alemtuzumab vs. interferon beta-1a in early multiple sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970094-6

7 January 2021

B-cell depletion with rituximab in relapsing-remitting multiple sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970094-6

7 January 2021

Monoclonal antibodies in MS: mechanisms of action

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970094-6

7 January 2021

Multiple sclerosis: a complicated picture of autoimmunity.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970094-6

7 January 2021

Pathogenic CD8(+) T cells in multiple sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970094-6

7 January 2021

The causal cascade to multiple sclerosis: a model for MS pathogenesis

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970094-6

7 January 2021

Environmental risk factors for multiple sclerosis. Part II: Noninfectious factors

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970094-6

7 January 2021

Smoking and disease progression in multiple sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970094-6

7 January 2021

Smoking is a risk factor for early conversion to clinically definite multiple sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970094-6

7 January 2021

Humoral immune response to EBV in multiple sclerosis is associated with disease activity on MRI.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970094-6

7 January 2021

Elevated Epstein-Barr virus-encoded nuclear antigen-1 immune responses predict conversion to multiple sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970094-6

7 January 2021

Toward constructing an endophenotype strategy for bipolar disorders

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970094-6

7 January 2021

Characterization of CD8+ T cell repertoire in identical twins discordant and concordant for multiple sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970094-6

7 January 2021

Evoked potential testing in relatives of multiple sclerosis patients

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970094-6

7 January 2021

Imaging brain damage in first-degree relatives of sporadic and familial multiple sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970094-6

7 January 2021

Abrogation of T cell quiescence characterizes patients at high risk for multiple sclerosis after the initial neurological event

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970094-6

7 January 2021

Integrating risk factors: HLA-DRB1*1501 and Epstein-Barr virus in multiple sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970094-6

7 January 2021

Differential twin concordance for multiple sclerosis by latitude of birthplace

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970094-6

7 January 2021

Incidence of CSF abnormalities in siblings of multiple sclerosis patients and unrelated controls

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970094-6

7 January 2021

Sex and age at diagnosis are correlated with the HLA-DR2, DQ6 haplotype in multiple sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970094-6

7 January 2021

HLA-DR 15 is associated with female sex and younger age at diagnosis in multiple sclerosis.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970094-6

7 January 2021

EBNA-1 reactivity and HLA DRB1*1501 as statistically independent risk factors for multiple sclerosis: a case-control study

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970094-6

7 January 2021

Effects of infectious mononucleosis and HLA-DRB1*15 in multiple sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970094-6

7 January 2021

Integration of genetic risk factors into a clinical algorithm for multiple sclerosis susceptibility: a weighted genetic risk score

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970094-6

7 January 2021

The influence of HLA-DR and -DQ alleles on progression to multiple sclerosis following a clinically isolated syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970094-6

7 January 2021

Interaction between HLA-DR2 and abnormal brain MRI in optic neuritis and early MS. Optic Neuritis Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970094-6

7 January 2021

10.1016/S1474-4422(10)70094-6

Identifiers

DOI

1 reference

release_glvoy6zjvremnf6j3sfeafe5fe

22 August 2017

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/glvoy6zjvremnf6j3sfeafe5fe

24 November 2022

mapped directly with Wikidata item

1 reference